CLOV vs VTRS · rev $1.37B vs rev $14.74B
Clover Health Investments Corp (CLOV) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
CLOV currently screens at market cap $1.55B. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the CLOV and VTRS stock pages for the full models.
Not investment advice.